Physician

Todd Edward Rambasek, MD

According to 2025 Medicare claims, Todd Rambasek, MD (NPI: 1093814220) practices allergy/immunology in the Cleveland, OH market, with the plurality of this provider's patient population coming from Cuyahoga, OH. This provider's primary affiliated billing organization is NORTHERN OHIO MEDICAL SPECIALISTS LLC (NPI: 1225085855; TIN: 341933718) and primary practice location at 44035-1494. Rambasek is affiliated with the Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.

Rambasek's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 338 traditional Medicare patients, billed 32,818 HCPCS/CPT codes, and received $695,182 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,576 prescription claims across 461 beneficiaries totaling $1,396,084 in drug costs, led by Takhzyro (Lanadelumab-Flyo). DME data shows 291 claims. Open Payments data shows 54 records totaling $3,702. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $136,886 to $695,182. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $230,867 to $1,396,084. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $854 to $6,762.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	267	8,358	$136,886
2016	283	10,178	$188,780
2017	295	14,342	$288,165
2018	269	12,175	$253,464
2019	265	12,833	$270,254
2020	243	12,060	$316,371
2021	295	19,837	$462,476
2022	309	22,514	$542,918
2023	315	34,273	$750,443
2024	338	32,818	$695,182

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	253	1,406	$230,867
2016	245	1,330	$362,043
2017	245	1,336	$507,078
2018	263	1,813	$737,852
2019	282	1,770	$805,423
2020	298	1,769	$1,221,898
2021	350	1,875	$1,143,865
2022	373	2,048	$1,138,892
2023	393	2,178	$1,159,530
2024	461	2,576	$1,396,084

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	12	$802
2016	N/R	N/R	N/R
2017	N/R	12	$51
2018	N/R	N/R	N/R
2019	N/R	89	$81,380
2020	N/R	117	$126,980
2021	N/R	141	$217,749
2022	N/R	217	$286,336
2023	N/R	196	$324,523
2024	N/R	291	$408,365

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	99	126	$90
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	107	107	$71
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	174	232	$63
95024	Test for allergy using allergenic extract injected into skin	90	729	$5
95004	Test for allergy using allergenic extract	100	3,235	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Takhzyro	Lanadelumab-Flyo	13	364	$325,955
Dupixent Syringe	Dupilumab	53	1,540	$202,616
Dupixent Pen	Dupilumab	43	1,344	$190,624
Xolair	Omalizumab	58	1,872	$165,451
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	101	4,110	$85,728

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	65	$307,513
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	N	N/R	22	$87,926
Q2052	Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)	N	N/R	17	$5,604
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	58	$4,362
J7626	Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg	N	N/R	21	$1,236

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	54	$3,702	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Todd Edward Rambasek, MD?

Tedicare shows public-source Medicare data for Todd Edward Rambasek, MD (NPI 1093814220), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Todd Edward Rambasek, MD have ACO affiliation data?

Todd Edward Rambasek, MD is shown with ACO affiliation data for Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Todd Edward Rambasek, MD?

Todd Edward Rambasek, MD is linked to NORTHERN OHIO MEDICAL SPECIALISTS LLC (billing NPI 1225085855) in the available physician profile data.

Does Todd Edward Rambasek, MD have Open Payments data?

Todd Edward Rambasek, MD has 54 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.